Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs

C. H. Lin, G. J. Chang, M. J. Su, Y. C. Wu, C. M. Teng, F. N. Ko

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The pharmacological activities of liriodenine, isolated from Fissistigma glaucescens, were determined in isolated trachea, ileum and cardiac tissues of guinea-pigs. Liriodenine was found to be a muscarinic receptor antagonist in guinea-pig trachea as revealed by its competitive antagonism of carbachol (pA2 = 6.22 ± 0.08)-induced smooth muscle contraction. It was slightly more potent than methoctramine (pA2 = 5.92 ± 0.05), but was less potent than atropine (pA2 = 8.93 ± 0.07), pirenzepine (pA2= 7.02 ± 0.09) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, pA2 = 8.72 ± 0.07). Liriodenine was also a muscarinic antagonist in guinea-pig ileum (pA2 = 6.36 ± 0.10) with a pA2 value that closely resembled that obtained in the trachea. Liriodenine was 10 fold less potent in atrial preparations (left atria, pA2 = 5.24 ± 0.04; right atria, pA2 = 5.35 ± 0.09 and 5.28 ± 0.07 for inotropic and chronotropic effects, respectively) than in smooth muscle preparations. High concentration of liriodenine (300 μM) partially depressed the contractions induced by U-46619, histamine, prostaglandin E(2α), neurokinin A, leukotriene C4 and high K+ in the guinea-pig trachea. The inhibitions were characterized by a rightward shift in the concentration-response curves with suppression of their maximal contraction. High concentration of liriodenine (300 μM) did not affect U-46619- or neurokinin A-induced tracheal contraction in the presence of nifedipine (1 μM) or in Ca2+-free (containing 0.2 mM EGTA) medium. Neither cyclic AMP nor cyclic GMP content of guinea-pig trachealis was changed by liriodenine (30-300 μM). It is concluded that liriodenine is a selective muscarinic receptor antagonist in isolated trachea, ileum and cardiac tissues of guinea-pigs. It is more potent in smooth muscle than in cardiac preparations. It also acts as a blocker of voltage-dependent Ca2+ channels at a high concentration (300 μM).

Original languageEnglish
Pages (from-to)275-281
Number of pages7
JournalBritish Journal of Pharmacology
Volume113
Issue number1
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Annonaceae
Muscarinic Antagonists
Muscarinic Receptors
Guinea Pigs
Pharmacology
Trachea
Ileum
Neurokinin A
Smooth Muscle
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Heart Atria
Pirenzepine
Leukotriene C4
liriodenine
Egtazic Acid
Cyclic GMP
Carbachol
Nifedipine
Muscle Contraction
Prostaglandins E

Keywords

  • Ca channel blocker
  • Fissistigma glaucescens
  • guinea-pig trachea
  • liriodenine
  • muscarinic receptor antagonist

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs. / Lin, C. H.; Chang, G. J.; Su, M. J.; Wu, Y. C.; Teng, C. M.; Ko, F. N.

In: British Journal of Pharmacology, Vol. 113, No. 1, 1994, p. 275-281.

Research output: Contribution to journalArticle

@article{110614f8ead94bbeb6363490a9b244a3,
title = "Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs",
abstract = "The pharmacological activities of liriodenine, isolated from Fissistigma glaucescens, were determined in isolated trachea, ileum and cardiac tissues of guinea-pigs. Liriodenine was found to be a muscarinic receptor antagonist in guinea-pig trachea as revealed by its competitive antagonism of carbachol (pA2 = 6.22 ± 0.08)-induced smooth muscle contraction. It was slightly more potent than methoctramine (pA2 = 5.92 ± 0.05), but was less potent than atropine (pA2 = 8.93 ± 0.07), pirenzepine (pA2= 7.02 ± 0.09) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, pA2 = 8.72 ± 0.07). Liriodenine was also a muscarinic antagonist in guinea-pig ileum (pA2 = 6.36 ± 0.10) with a pA2 value that closely resembled that obtained in the trachea. Liriodenine was 10 fold less potent in atrial preparations (left atria, pA2 = 5.24 ± 0.04; right atria, pA2 = 5.35 ± 0.09 and 5.28 ± 0.07 for inotropic and chronotropic effects, respectively) than in smooth muscle preparations. High concentration of liriodenine (300 μM) partially depressed the contractions induced by U-46619, histamine, prostaglandin E(2α), neurokinin A, leukotriene C4 and high K+ in the guinea-pig trachea. The inhibitions were characterized by a rightward shift in the concentration-response curves with suppression of their maximal contraction. High concentration of liriodenine (300 μM) did not affect U-46619- or neurokinin A-induced tracheal contraction in the presence of nifedipine (1 μM) or in Ca2+-free (containing 0.2 mM EGTA) medium. Neither cyclic AMP nor cyclic GMP content of guinea-pig trachealis was changed by liriodenine (30-300 μM). It is concluded that liriodenine is a selective muscarinic receptor antagonist in isolated trachea, ileum and cardiac tissues of guinea-pigs. It is more potent in smooth muscle than in cardiac preparations. It also acts as a blocker of voltage-dependent Ca2+ channels at a high concentration (300 μM).",
keywords = "Ca channel blocker, Fissistigma glaucescens, guinea-pig trachea, liriodenine, muscarinic receptor antagonist",
author = "Lin, {C. H.} and Chang, {G. J.} and Su, {M. J.} and Wu, {Y. C.} and Teng, {C. M.} and Ko, {F. N.}",
year = "1994",
language = "English",
volume = "113",
pages = "275--281",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs

AU - Lin, C. H.

AU - Chang, G. J.

AU - Su, M. J.

AU - Wu, Y. C.

AU - Teng, C. M.

AU - Ko, F. N.

PY - 1994

Y1 - 1994

N2 - The pharmacological activities of liriodenine, isolated from Fissistigma glaucescens, were determined in isolated trachea, ileum and cardiac tissues of guinea-pigs. Liriodenine was found to be a muscarinic receptor antagonist in guinea-pig trachea as revealed by its competitive antagonism of carbachol (pA2 = 6.22 ± 0.08)-induced smooth muscle contraction. It was slightly more potent than methoctramine (pA2 = 5.92 ± 0.05), but was less potent than atropine (pA2 = 8.93 ± 0.07), pirenzepine (pA2= 7.02 ± 0.09) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, pA2 = 8.72 ± 0.07). Liriodenine was also a muscarinic antagonist in guinea-pig ileum (pA2 = 6.36 ± 0.10) with a pA2 value that closely resembled that obtained in the trachea. Liriodenine was 10 fold less potent in atrial preparations (left atria, pA2 = 5.24 ± 0.04; right atria, pA2 = 5.35 ± 0.09 and 5.28 ± 0.07 for inotropic and chronotropic effects, respectively) than in smooth muscle preparations. High concentration of liriodenine (300 μM) partially depressed the contractions induced by U-46619, histamine, prostaglandin E(2α), neurokinin A, leukotriene C4 and high K+ in the guinea-pig trachea. The inhibitions were characterized by a rightward shift in the concentration-response curves with suppression of their maximal contraction. High concentration of liriodenine (300 μM) did not affect U-46619- or neurokinin A-induced tracheal contraction in the presence of nifedipine (1 μM) or in Ca2+-free (containing 0.2 mM EGTA) medium. Neither cyclic AMP nor cyclic GMP content of guinea-pig trachealis was changed by liriodenine (30-300 μM). It is concluded that liriodenine is a selective muscarinic receptor antagonist in isolated trachea, ileum and cardiac tissues of guinea-pigs. It is more potent in smooth muscle than in cardiac preparations. It also acts as a blocker of voltage-dependent Ca2+ channels at a high concentration (300 μM).

AB - The pharmacological activities of liriodenine, isolated from Fissistigma glaucescens, were determined in isolated trachea, ileum and cardiac tissues of guinea-pigs. Liriodenine was found to be a muscarinic receptor antagonist in guinea-pig trachea as revealed by its competitive antagonism of carbachol (pA2 = 6.22 ± 0.08)-induced smooth muscle contraction. It was slightly more potent than methoctramine (pA2 = 5.92 ± 0.05), but was less potent than atropine (pA2 = 8.93 ± 0.07), pirenzepine (pA2= 7.02 ± 0.09) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, pA2 = 8.72 ± 0.07). Liriodenine was also a muscarinic antagonist in guinea-pig ileum (pA2 = 6.36 ± 0.10) with a pA2 value that closely resembled that obtained in the trachea. Liriodenine was 10 fold less potent in atrial preparations (left atria, pA2 = 5.24 ± 0.04; right atria, pA2 = 5.35 ± 0.09 and 5.28 ± 0.07 for inotropic and chronotropic effects, respectively) than in smooth muscle preparations. High concentration of liriodenine (300 μM) partially depressed the contractions induced by U-46619, histamine, prostaglandin E(2α), neurokinin A, leukotriene C4 and high K+ in the guinea-pig trachea. The inhibitions were characterized by a rightward shift in the concentration-response curves with suppression of their maximal contraction. High concentration of liriodenine (300 μM) did not affect U-46619- or neurokinin A-induced tracheal contraction in the presence of nifedipine (1 μM) or in Ca2+-free (containing 0.2 mM EGTA) medium. Neither cyclic AMP nor cyclic GMP content of guinea-pig trachealis was changed by liriodenine (30-300 μM). It is concluded that liriodenine is a selective muscarinic receptor antagonist in isolated trachea, ileum and cardiac tissues of guinea-pigs. It is more potent in smooth muscle than in cardiac preparations. It also acts as a blocker of voltage-dependent Ca2+ channels at a high concentration (300 μM).

KW - Ca channel blocker

KW - Fissistigma glaucescens

KW - guinea-pig trachea

KW - liriodenine

KW - muscarinic receptor antagonist

UR - http://www.scopus.com/inward/record.url?scp=0028104008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028104008&partnerID=8YFLogxK

M3 - Article

VL - 113

SP - 275

EP - 281

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -